Novo Nordisk shares are trading higher after the company announced a partnership with OpenAI to integrate AI from drug discovery to commercial operations.

Benzinga Newsdesk www.benzinga.com Positive 94.9%

Neg 0% Neu 0% Pos 94.9%

Comments

No comments yet. Be the first!